Poster Titles
CBI2008       Poster Presentations: Titles

Research Topic
No.0 Nuclear Receptors and Metabolic Syndrome
No.1 Molecular Computing
No.2 Molecular Recognition
No.3 Bioinformatics and Bio Computing
No.4 Genome Wide Experimental Data Analyses
No.5 Information and Computing Infrastructure for Drug Design and Toxicology
No.6 Disease Mechanism and Control Model
No.7 Emerging New Technology

Poster No. Title
P0-01 SAR-oriented discovery of substituted phenyl propanoic acid-based peroxisome proliferator-activated receptor (PPAR) pan agonists as candidate antipancreatic cancer agents
P0-02 Development of the ligand screening system of the peroxisome proliferator-activated receptors to ameliorate the metabolic syndrome
P0-03 Lithocholic acid derivatives act as VDR agonists without hypercalcemia.
P0-04 Estimation of practical cut-off point of relative binding affinity to estrogen receptor which determine the presence or absence of in vivo uterotrophic activity of chemicals
P0-05 DEC is a nuclear receptor co-repressor
P0-06 Novel VDR agonists bearing carborane: Synthesis, biological activity and VDR binding structure
P0-07 A Portal for Nuclear Receptors and Metabolic Syndrome Research II
P0-08 Study of the crosstalk in regulatory networks of adipogenetic and osteogenetic differentiation
P0-09 Estrogen-related receptor is a target gene of PPAR in adipocyte differentiation
P0-10 Structure-Based Design of Novel Side Chain Analogs for the Vitamin D Nuclear Receptor
P0-11 GGPP performs as an endogenous negative regulator of adipocyte differentiation
P0-12 Systemic identification of common and unique response genes for various steroid hormones in the human ENCODE genomic regions
P0-13 Estrogen-related receptors in fats and adipogenesis
P0-14 Bile acid binding resins improve obesity and insulin resistance
P1-01 Biomolecular Computations on Needed Effects and Unwanted Effects of HIV-1 Protease Inhibitors with Fragment Molecular Orbital Method
P1-02 Computational studies for the role of the disulfide bond in UGT1A1 by using homology modeling and molecular dynamics simulations
P1-03 Relationship between Structural Fluctuation and Positions of Helix 12 in the Nuclear Receptors Studied by Molecular Dynamics Simulation
P1-04 Molecular Dynamics Study of the Effect of Arg344 Mutation on the Activation of Human Cathepsin A
P1-05 Theoretical study of molecular interaction in prion protein based on fragment molecular orbital method
P1-06 Aqueous solubility prediction by a neural network model with using calculated physical properties from 3D structures of molecule
P1-07 Study of All-electron Calculation of Putative Acylphosphatase Using Structure-based QCLOs method
P1-08 Molecular Mechanics and Fragment Molecular Orbital calculations on Specific Interactions between Thermolysin and Dipeptide Ligands
P1-09 Ab initio Fragment Molecular Orbital Studies on Specific Interactions between Aryl Hydrocarbon Receptor and Halogenated Aromatic Hydrocarbons
P1-10 Docking simulation of factor Xa and its inhibitors by force-biased multicanonical molecular dynamics
P1-11 Applying QCMD methods to the Analysis of the Catalytic Function of Proteinases
P1-12 A New Method for Prediction of Protein-Ligand Interactions by means of Knowledge Based Potential
P1-13 Secondary Structure Tendency of Substrate Cleavage Site Influences Substrate Binding of HIV-1 Protease
P1-14 Calculation of QM Electrostatic Potential on Protein Surface
P1-15 Determination of ESP charges on polypeptides using the fragment molecular orbital method and the applications for molecular simulations
P1-16 Ab initio fragment molecular orbital calculations of binding of bisphosphonates to farnesyl diphosphate synthase
P2-01 Molecular Basis for Selective Toxicity of an agrochemical fungicide Cyazofamid
P2-02 Analyses of the ligand-protein interaction in complex structures from Protein Data Bank and Cambridge Structural Database
P2-03 Theoretical study of protoporphyrinogen IX oxidation mechanism in protoporphyrinogen oxidase
P2-04 Small anti-HIV compounds found with in silico screening and MTT assay
P2-05 Calculation of Binding Free Energies of Protein-Ligand Complexes with the Molecular dynamics simulation in explicit water model
P2-06 Construction, expression and characterization of chimera olfactory receptor
P2-07 Purification and function characterization of sHsp18.0 from the magnetotactic bacterium Magnetospirillum magneticum AMB-1
P2-08 Expression, purification, and functional characterization of Hsp40, Hsp70, and Hsp104 from the fission yeast, Schizosaccharomyces pombe
P2-09 3D structure modeling of Tn-antigen specific antibodies, MLS128 and 83D4
P3-01 Boosting the area under the ROC curve for clinical outcome prediction
P3-02 Predicting druggable protein-protein interactions by a machine-learning method
P3-03 A global view of drug-therapy interactions
P3-04 Docking Analysis of the Weak Interaction between Ligand Peptides and a Soluble Receptor Using software
P3-05 An OLAP-Based Multi-Dimensional Analysis Technique for Protein-Protein Interaction Network
P3-06 Study on the Effect of H168R Suppressor Mutation on R249S p53-DNA Interaction by Ultra Accelerated Quantum Chemical Molecular Dynamics Simulation.
P3-07 Structural analysis of the disease-causing mutations in protein structure using accelerated quantum chemical molecular dynamics technique
P3-08 Applying Ultra Accelerated Quantum Chemical Molecular Dynamics Method to Study the Role of NADPH in Reduction of Dihydrofolic Acid
P3-09 Affinity Evaluation and Prediction for Protein-Protein Docking
P3-10 Genotype prediction of HIV-1 drug resistance using logic regression
P3-11 A Semantic Web-based database integration system as an infrastructure of biomedical informatics
P3-12 On Robustness of Signal Transduction Networks for NR-SX: Structural Analysis of Cell Cycle Control in Yeast
P3-13 Sequence Analysis of Nuclear Export Signals
P3-14 Finding indels with short sequencing reads
P3-15 Development and implementation of an algorithm for searching similar local structure
P3-16 Analysis of cis-element regularity by informatics approach
P3-17 The Optimum Estimation of Signals Using Discrete Sample Values
P3-18 Generation of hypothetical metabolic networks for pathway prediction
P3-19 Comprehensive search for new mitochondrial beta-barrel outermembrane proteins
P4-01 Development of an integrated approach for analysis of time-course microarray data using transcription factor and molecular function databases
P4-02 Identification of Novel PPAR Target Genes and Response Elements by Integrated Analysis of ChIP-on-chip and Microarray Expression Data during 3T3-L1 Adipocyte Differentiation.
P4-03 Expressional profiling in Cacna1b gene knockout mouse hippocampus
P4-04 New Bioinformatics program for the extraction of biological intelligence from transcriptome: the case of low-dose-rate radiation research
P5-01 Landscapes of Solubility and Metabolic Stability on Molecular Weight-Lipophilicity Maps
P5-02 Kinetic assessment and strategy for oral prodrugs overcoming biological membrane barriers and luminal degradation: a study on successful prodrug
P5-03 High-performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations
P5-04 A novel use of protomols in Surflex-Dock: Searching for binding sites with a global protomol
P5-05 Molecular docking study on the human mu opioid receptor
P5-08 A Comprehensive Analysis of Protein Kinase Information
P5-09 Non-target metabolic profiling with micro-volume samples by conventional solution NMR spectrometers
P5-10 In Silico Prediction of Side Effect via the Specificities of Kinase Inhibitors
P5-11 Statistical Pattern Recognition Analysis for NMR Spectra of Blood Plasma from Patients with Chronic Kidney Disease
P5-12 A web-based procedure database for mouse phenotype analyses
P5-13 Nuclear Receptor Cofactor Assay System ( RCAS ) - non-RI in vitro screening system -
P5-14 Evaluation of a chemical genomics-based virtual screening
P6-01 Elucidation of the deregulation of G1/S transition induced by DNA-damage at late G1 phase
P6-02 How does p53 regulate implementations of both cell-cycle and apoptosis?
P6-03 in silico estimation for the enzyme activity of mutant UDP-glucuronosyltransferase 1A1
P6-04 Mouse inter-subspecific consomic strains for the study of energy metabolism-related traits
P7-01 Cold-adaptation of hyperthermophilic group II chaperonin
P7-02 Discovery of blood biomarkers to predict sensitivity to CPT-11 by metabolome analysis
P7-03 CE-TOFMS metabolome analysis of intracellular metabolite kinetics after 5-FU exposure
P7-04 Protein biomarkers for predicting sensitivity to Oxaliplatin by SELDI-TOF MS screening